UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Explore various ways to grow wealth with low risk that can help you achieve financial security. Start making informed investment choices today.
27,305 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Bitcoin surged past $70,000 on signs that U.S. actions against Iran would be paused for five days, sparking a broad r...
Great Elm's Q3 2026 earnings shed light on growth, margins, and capital allocation. This article breaks down the numb...
As of March 31, 2026, NVIDIA, Apple, and Microsoft account for roughly 43% of VGT, raising questions about true diver...
Stocks push to new highs as AI-driven earnings lift equities, while bitcoin falling behind record-breaking rallys rem...
Rug pulls remain the dominant crypto scam, representing more than half of new detections in June 2026. The latest dat...
MemeCore’s M token plunged 76% in 24 hours, while MIM depegged to $0.50, triggering emergency measures by its develop...
Could SpaceX expand from rockets to handheld devices? This article examines the idea of spacex planning make smartpho...
Rivian’s latest forecast sent a wave through the stock. But should you buy now or wait? This guide breaks down the de...
A wave of fresh users on Polymarket produced sizable winnings in a single session amid rising geopolitical tension, u...
Investors weigh Amazon's Zoox-related progress against UPS's strategic shifts while oil volatility stirs the market. ...
As Iran-related conflict enters its fourth week, airlines brace for a fuel-cost shock even as travelers return and fa...